BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 6888825)

  • 1. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K; Satgunasingam N; Nasri NM; Ng KY
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual clinical course after mole evacuation: a case report.
    Okamoto T; Nakanishi T; Nomura S; Goto S; Sakaida H; Tomoda Y
    Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
    Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC; Wong LC; Ma HK
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
    Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
    Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Partial hydatidiform mole with significantly increased serum HCG levels in the triploidy syndrome].
    Arnholdt H; Elser H; Dörmer P
    Geburtshilfe Frauenheilkd; 1984 May; 44(5):328-32. PubMed ID: 6565615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB; Granai CO; Ball HG; Curry SL
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract]   [Full Text] [Related]  

  • 16. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G; Pürstner P
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P; Leyendecker G
    Arch Gynecol; 1979 Jul; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.